On a national level, the Medicaid population has grown by 11 million since 1996 and has increasingly spread into managed care. Ten years ago, 40.1% of the 33 million Medicaid enrollees were covered by managed care plans, and as of June 2004, 60.6% of 44 million enrollees were covered by managed care, according to the Centers for Medicare and Medicaid Services.
On a national level, the Medicaid population has grown by 11 million since 1996 and has increasingly spread into managed care. Ten years ago, 40.1% of the 33 million Medicaid enrollees were covered by managed care plans, and as of June 2004, 60.6% of 44 million enrollees were covered by managed care, according to the Centers for Medicare and Medicaid Services.
iCare's members are residents of Milwaukee County who qualify for the federal Supplemental Security Income (SSI) cash assistance program, often referred to in the past as "disability welfare." Approximately 17% of Americans covered by Medicaid qualify for SSI because of physical disability, developmental disability, mental retardation or serious mental illness. According to Jerominski, the problem is that managed care is largely underutilized on a national basis for this costly population.
When the organization began in 1994 under a three-year federal grant, its purpose was to demonstrate the cost effectiveness of managed care for SSI individuals. A not-for-profit community organization and a licensed HMO joined together to form iCare and began the process of developing appropriate capitation rates.
"Analyzing the state's data to assess the utilization of this population is challenging," Jerominski says. "When the state of Wisconsin first met with iCare, they reported there were a lot of developmentally delayed individuals in the population who aren't very costly, so they thought the capitation rate should be about $300 PMPM. A week later, they believed there were more physical disabilities in the population, and said the rate should be $1,300 PMPM. That's a huge difference."
She says a trust issue between the state and iCare also came into play during negotiations because the state data needed to determine rates was not reliable. Eventually a risk-sharing program was developed. In the first year, a capitation payment of $575 PMPM was paid to iCare with a 2% risk sharing corridor. iCare agreed to share profits above 2%, and the state agreed to share losses greater than 2%. The plan saw consecutive losses the first few years. In 1997, the state of Wisconsin began to get uncomfortable with the financial exposure but continued contracting on a month-to-month basis.
Jerominski says pent up demand for the managed care SSI arrangement was significant, and the start-up costs certainly weighed the plan down initially. The state was willing to be patient but needed to determine the viability of the investment moving forward with little data to go on. Collectively, they developed a new arrangement that shifted the risk away from the state and onto iCare.
A Conversation With Greg Baker, RPh, CEO of AffirmedRx
March 31st 2024Greg Baker, CEO of AffirmedRx, describes his early career, shares some of his critical opinions about the pharmacy benefit management (PBM) industry and how, in his view, his company is offering a better alternative.
Read More
David Calabrese of OptumRx Talks New Role, Market Insulin Prices and Other Topics 'On His Mind'
April 13th 2023In this month’s episode of the "What's On Your Mind podcast," Peter Wehrwein, managing editor of MHE connects with the now Chief Clinical Officer of OptumRx Integrated Pharmacies, David Calabrese. In this conversation, David touches on his transition in January as OptumRx’s former chief pharmacy officer and market president of health plans and PBMs to his new role as Chief Clinical Officer where he now focuses more on things such as specialty pharmacy to home delivery — with an overall goal of creating whole-patient care. Throughout the conversation, Calabrese also touched on the market’s hot topic of insulin prices and behavioral health services within the OptumRx community, among other topics.
Listen
Florida Gets the OK. But Will Drug Importation from Canada Actually Happen?
March 5th 2024Canadian health officials warn that maintaining a drug supply for Canadians is their priority. The staunch opposition of the U.S. pharmaceutical industry may also be an obstacle to imports from north of the border.
Read More
Briana Contreras, editor of Managed Healthcare Executive, spoke with Nancy Lurker, CEO and president of EyePoint Pharmaceuticals. Nancy shared a bit about EyePoint and how the organization’s innovative therapies are addressing patient needs through eye care, and most importantly, she addressed C-Suite positions like the CEO role. Nancy shared advice for those seeking to reach the CEO level, especially toward women in healthcare and other roles, and what it takes to run a biopharma company.
Listen
What Payers Need to Know As Retail Pharmacies Move Into Primary Care
September 6th 2023Healthcare beyond the doors of the doctor’s office has the potential to offer more care to more people. But payers need to think about how to ensure that care is consistent. Regardless of the setting, care decisions must be based on evidence-based content and supported with strong patient education.
Read More